Crispr Therapeutics shares tumble after significant earnings miss
Investing.com - Hub Group (NASDAQ: HUBG) reported second quarter EPS of $0.45, $0.01 better than the analyst estimate of $0.44. Revenue for the quarter came in at $905.6M versus the consensus estimate of $918.11M.
Guidance
Hub Group sees FY 2025 EPS of $1.80-$2.05 versus the analyst consensus of $1.90.
Hub Group sees FY 2025 revenue of $3.60B-$3.80B versus the analyst consensus of $3.77B.
Hub Group’s stock price closed at $35.02. It is up 6.51% in the last 3 months and down -24.20% in the last 12 months.
Hub Group saw 0 positive EPS revisions and 12 negative EPS revisions in the last 90 days. See Hub Group’s stock price’s past reactions to earnings here.
According to InvestingPro, Hub Group’s Financial Health score is "fair performance".
Check out Hub Group’s recent earnings performance, and Hub Group’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar